Farting (flatulence). (N.d.). Retrieved 30 September 2024, from https://www.nhs.uk/conditions/flatulence/
Le Trionnaire, S., Perry, A., Szczesny, B., Szabo, C., Winyard, P. G., Whatmore, J. L., … & Whiteman, M. (2014). The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor,(10-oxo-10-(4-(3-thioxo-3 H-1, 2-dithiol-5-yl) phenoxy) decyl) triphenylphosphonium bromide (AP39). MedChemComm, 5(6), 728-736.
Szczesny, B., Módis, K., Yanagi, K., Coletta, C., Le Trionnaire, S., Perry, A., Wood, M. E., Whiteman, M., & Szabo, C. (2014). AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric oxide : biology and chemistry, 41, 120–130. https://doi.org/10.1016/j.niox.2014.04.008
Tomasova, L., Pavlovicova, M., Malekova, L., Misak, A., Kristek, F., Grman, M., Cacanyiova, S., Tomasek, M., Tomaskova, Z., Perry, A., Wood, M. E., Lacinova, L., Ondrias, K., & Whiteman, M. (2015). Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels. Nitric oxide : biology and chemistry, 46, 131–144. https://doi.org/10.1016/j.niox.2014.12.012
Latorre, E., Torregrossa, R., Wood, M. E., Whiteman, M., & Harries, L. W. (2018). Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2. Aging, 10(7), 1666–1681. https://doi.org/10.18632/aging.101500